Advanced Materials Aerospace & defense Agriculture Automation & Process Control Automotive & Transportation Banking & Financial Services Biotechnology Building & Construction Chemicals Cloud Computing Communications Devices and Infrastructure Consumer Goods Country Reports Cyber Security Data Center & Networking Energy Energy Utilities Food & Beverage Global Reports Healthcare Industrial Goods Industry Updates Information and Communications Technology IoT, Bigdata & Digitalization IT & Telecom Medical Devices Mining, Minerals and Metals Networking and Communications Next-Generation Networking Technologies Oil & Gas Outsourcing Services Packaging Pharmaceuticals Regional Reports Semiconductor & Electronics Software & Solutions Technology & Media Travel & Tourism
-
Antifungal Drugs Market
The Antifungal drugs market size was valued at USD 13200.74 million in 2024 and is anticipated to reach USD 17115.94 million by 2032, at a CAGR of 3.3% during the forecast period.
-
N-Acetylcysteine Market
The Global N-Acetylcysteine Market size was valued at USD 1,230 million in 2018 to USD 2,219.09 million in 2024 and is anticipated to reach USD 8,916.16 million by 2032, at a CAGR of 19.11% during the forecast period.
-
Africa Pharmaceutical Market
The Africa Pharmaceutical Market size was valued at USD 36,000.03 million in 2018, reaching USD 59,937.14 million in 2024, and is anticipated to attain USD 122,041.15 million by 2032, growing at a CAGR of 8.66% during the forecast period.
-
Extended Release Drugs Market
The Global Extended Release Drugs Market size was valued at USD 34,191.80 million in 2018 to USD 63,002.70 million in 2024 and is anticipated to reach USD 138,831.20 million by 2032, at a CAGR of 9.67% during the forecast period.
-
Self-Administered Drugs Market
The Self-Administered Drugs Market was valued at USD 22.7 billion in 2024 and is projected to reach USD 28.84 billion by 2032, growing at a CAGR of 3.04% during the forecast period.
-
Epilepsy Drugs Market
The Global Epilepsy Drugs Market size was valued at USD 7,231.85 million in 2018, increased to USD 10,689.80 million in 2024, and is anticipated to reach USD 17,219.01 million by 2032, at a CAGR of 5.72% during the forecast period.
-
Dupuytren’s Disease Therapeutics Market
Dupuytren’s Disease Therapeutics Market size was valued at USD 270.5 million in 2024 and is anticipated to reach USD 408.88 million by 2032, at a CAGR of 5.3% during the forecast period.
-
MA Therapeutics Market
MA Therapeutics market size was valued at USD 7.55 billion in 2024 and is anticipated to reach USD 20.67 billion by 2032, at a CAGR of 13.42% during the forecast period.
-
Sleep Disorders Treatment Drugs Market
Sleep Disorders Treatment Drugs Market size was valued at USD 28.34 Billion in 2024 and is anticipated to reach USD 71.69 Billion by 2032, at a CAGR of 12.3% during the forecast period.
-
Smart Drug Delivery Systems Market
The Smart Drug Delivery Systems Market size was valued at USD 12.66 billion in 2024 and is anticipated to reach USD 53.72 billion by 2032, at a CAGR of 19.8% during the forecast period.
